ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Deciphering the mechanism of PSORI-CM02 in suppressing keratinocyte proliferation through the mTOR/HK2/glycolysis axis

Wang, Maojie; Tang, Bin; Huang, Huanjie; Wu, Xiaodong; Deng, Hao; Chen, Haiming; Mei, Liyan; Chen, Xiumin; Burgering, Boudewijn*; Lu, Chuanjian*广东省人民医院; 广州中医药大学; 中国医科大学
Frontiers in Pharmacology2023-4-7DOI: 10.3389/fphar.2023.1152347
19阅读
引用收藏
分享

摘要

Hyperplasia of epidermal keratinocytes that depend on glycolysis is a new hallmark of psoriasis pathogenesis. Our previous studies demonstrated that PSORI-CM02 could halt the pathological progression of psoriasis by targeting inflammatory response and angiogenesis, but its effect(s) and mechanism(s) on proliferating keratinocytes remained unclear. In this study, we aim to identify components of PSORI-CM02 that are absorbed into the blood and to determine the effect(s) of PSORI-CM02 on keratinocyte proliferation and its molecular mechanism(s). We used the immortalized human epidermal keratinocyte cell line, HaCaT, as an in vitro model of proliferating keratinocytes and the imiquimod-induced psoriasis mouse (IMQ) as an in vivo model. Metabolite profiles of vehicle pharmaceutic serum (VPS), PSORI-CM02 pharmaceutic serum (PPS), and water extraction (PWE) were compared, and 23 components of PSORI-CM02 were identified that were absorbed into the blood of mice. Both PPS and PWE inhibited the proliferation of HaCaT cells and consequently reduced the expression of the proliferation marker ki67. Additionally, PPS and PWE reduced phosphorylation levels of mTOR pathway kinases. Seahorse experiments demonstrated that PPS significantly inhibited glycolysis, glycolytic capacity, and mitochondrial respiration, thus reducing ATP production in HaCaT cells. Upon treatments of PPS or PWE, hexokinase 2 (HK2) expression was significantly decreased, as observed from the set of glycolytic genes we screened. Finally, in the IMQ model, we observed that treatment with PSORI-CM02 or BPTES, an inhibitor of mTOR signaling, reduced hyperproliferation of epidermal keratinocytes, inhibited the expression of p-S6 and reduced the number of proliferating cell nuclear antigen (PCNA)-positive cells in lesioned skin. Taken together, we demonstrate that PSORI-CM02 has an anti-proliferative effect on psoriatic keratinocytes, at least in part, by inhibiting the mTOR/HK2/glycolysis axis.

学科与关键词

关键词
psoriasisPSORI-CM02proliferating keratinocytesmammalian target of rapamycinhexokinase 2
相关
加载中…
  • Punicalagin alleviates the hyperproliferation of keratinocytes in psoriasis through inhibiting SKP2 expression
    Tang, Lipeng; Zhang, Bowen; Li, Guanzhuo; Zhu, Ying; Feng, Bing; Su, Zuqing; Han, Wenhui; Huang, Huilin; Li, Qiuping; Wang, Maojie; Chen, Yuchao; Liu, Huazhen; Dai, Zhenhua; Wu, Dinghong; Li, Hongxia; Yang, Laijun; Lu, Yanjing; Ye, Zeting; Zheng, Guangjuan*Journal of Natural Medicines, 2023, 77(4): 712-720.被引 1
  • Study on the Key Genes and Molecular Mechanisms of IL-27 Promoting Keratinocytes Proliferation Based on Transcriptome Sequencing
    Wu, Zijun; Yang, Qin; Xu, Kai; Wu, Juanjuan; Yang, Bin*Clinical, Cosmetic and Investigational Dermatology, 2023, 16: 1457-1472.
  • Increase of ISG15 in psoriasis lesions and its promotion of keratinocyte proliferation via the Hif-1a signalling pathway
    Sun, Xianqi; Li, Yuzhen*Experimental Dermatology, 2023, 32(11): 1971-1981.
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Pharmacology
发表日期
2023-04-07
卷期
第 14 卷
页码
1152347
DOI
10.3389/fphar.2023.1152347
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81873302, U20A20397]; China-Dutch special projects of Guangdong Provincial Hospital of Chinese Medicine [YN2019HL02, YN2019HL03]; Key-Area Research and Development Program of Guangdong Province [2020B1111100005]; The 2020 Guangdong Provincial Science and Technology Innovation Strategy Special Fund (Guangdong-Hong Kong-Macau Joint Lab) [2020B1212030006]; Specific Fund of State Key Laboratory of Dampness Syndrome of Chinese Medicine [SZ2021KF16]; Science and Technology Planning Project of Guangzhou [202206080006]; The 2022 TCM Innovation Team and Talent Support Program of the State Administration of Traditional Chinese Medicine [ZYYCXTD-C-202204]

作者

  • W

    Wang, Maojie (第一作者)

    guangzhou univ chinese med · 2 · guangdong prov hosp

  • T

    Tang, Bin

    2 · guangdong prov hosp · guangzhou univ chinese med

查看全部 10 位作者收起作者
  • H

    Huang, Huanjie

    2 · guangdong prov hosp · guangzhou univ chinese med

  • W

    Wu, Xiaodong

    2 · guangdong prov hosp · guangzhou univ chinese med

  • D

    Deng, Hao

    2 · guangdong prov hosp · guangzhou univ chinese med

  • C

    Chen, Haiming

    2 · guangdong prov hosp · guangzhou univ chinese med

  • M

    Mei, Liyan

    2 · guangdong prov hosp · guangzhou univ chinese med

  • C

    Chen, Xiumin

    2 · guangdong prov hosp · guangzhou univ chinese med

  • B

    Burgering, Boudewijn (通讯)

  • L

    Lu, Chuanjian (通讯)

    guangzhou univ chinese med · 2 · guangdong prov hosp

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417